ModelEdge

Inozyme Pharma Inc.
INZY
Filing Type8-K
Filing Date6/30/2025
Updated7/1/25, 7:25 AM

Filing

8-K
Earnings Release

Exhibits

8-KEnd of Material Contract, Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws
EX-3.1EX-3.1
EX-3.2EX-3.2